Anthony V. Serritella

806 total citations
30 papers, 467 citations indexed

About

Anthony V. Serritella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Anthony V. Serritella has authored 30 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Anthony V. Serritella's work include Prostate Cancer Treatment and Research (7 papers), Economic and Financial Impacts of Cancer (5 papers) and CAR-T cell therapy research (4 papers). Anthony V. Serritella is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Economic and Financial Impacts of Cancer (5 papers) and CAR-T cell therapy research (4 papers). Anthony V. Serritella collaborates with scholars based in United States, Israel and Canada. Anthony V. Serritella's co-authors include Thomas W. Sedlak, Minori Koga, Akira Sawa, Bryan Peterson, Katherine I. Zhou, Daniel V.T. Catenacci, Natalie Reizine, Stephanie Moya, Joseph Thomas and Garth W. Strohbehn and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anthony V. Serritella

29 papers receiving 460 citations

Peers

Anthony V. Serritella
Mark Han United States
Jaclyn Neo Australia
S Golding United Kingdom
Anthony V. Serritella
Citations per year, relative to Anthony V. Serritella Anthony V. Serritella (= 1×) peers Roberto Catalán

Countries citing papers authored by Anthony V. Serritella

Since Specialization
Citations

This map shows the geographic impact of Anthony V. Serritella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony V. Serritella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony V. Serritella more than expected).

Fields of papers citing papers by Anthony V. Serritella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony V. Serritella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony V. Serritella. The network helps show where Anthony V. Serritella may publish in the future.

Co-authorship network of co-authors of Anthony V. Serritella

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony V. Serritella. A scholar is included among the top collaborators of Anthony V. Serritella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony V. Serritella. Anthony V. Serritella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desai, Kunal, Anthony V. Serritella, Walter M. Stadler, et al.. (2024). A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 30(11). 2384–2392. 3 indexed citations
2.
Serritella, Anthony V., Payal Dhar, Sizhe Liu, et al.. (2024). The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes. Biomedicines. 12(1). 196–196. 2 indexed citations
3.
Sehgal, Kartik, Anthony V. Serritella, Anne O’Neill, et al.. (2024). A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 110(5). 1315–1323. 5 indexed citations
4.
Serritella, Anthony V., Amy K. Taylor, Michael Haffner, et al.. (2024). Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2). Prostate Cancer and Prostatic Diseases. 28(3). 601–609. 4 indexed citations
5.
Serritella, Anthony V. & Maha Hussain. (2024). Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy. Current Treatment Options in Oncology. 25(3). 293–312. 4 indexed citations
6.
Armstrong, Andrew J., Amy K. Taylor, Michael Haffner, et al.. (2024). Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2). Prostate Cancer and Prostatic Diseases. 28(3). 652–661. 6 indexed citations
7.
Wu, Jennifer D., et al.. (2024). Abstract 6356: Novel antibody targeting tumor NKG2D ligand MIC: Preclinical studies and clinical development plan for mCRPC. Cancer Research. 84(6_Supplement). 6356–6356. 1 indexed citations
8.
Serritella, Anthony V., et al.. (2023). Retrospective analysis of NUT carcinoma: The Northwestern experience.. Journal of Clinical Oncology. 41(16_suppl). e18096–e18096.
9.
Clarke, Michael F., Krittika Teerapuncharoen, Anthony V. Serritella, et al.. (2023). Long-Term Outcomes of Patients With Pulmonary Embolism Managed With Endovascular Therapies Compared to Medical Therapy. Journal of the Society for Cardiovascular Angiography & Interventions. 2(3). 100602–100602. 1 indexed citations
10.
Serritella, Anthony V. & Niraj Shenoy. (2023). Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma. JAMA Oncology. 9(10). 1441–1441. 17 indexed citations
11.
Serritella, Anthony V., Pablo Sáenz-López, Payal Dhar, Sizhe Liu, & Jennifer D. Wu. (2023). The clinical impact of soluble natural killer cell group 2-member D (NKG2D) receptor ligands on tumor tumorigenicity and anti-tumor immunity.. Journal of Clinical Oncology. 41(16_suppl). e14557–e14557. 1 indexed citations
12.
Mahalingam, Devalingam, Anthony V. Serritella, Christos Fountzilas, et al.. (2023). Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer. Oncotarget. 14(1). 622–636. 7 indexed citations
13.
Kacew, Alec, et al.. (2022). Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. npj Breast Cancer. 8(1). 32–32. 12 indexed citations
14.
Carey, Kyle A., Anthony V. Serritella, John E. Blair, et al.. (2021). Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population. Journal of Thrombosis and Thrombolysis. 52(4). 1151–1159. 2 indexed citations
15.
Zhou, Katherine I., Bryan Peterson, Anthony V. Serritella, et al.. (2020). Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy. Clinical Cancer Research. 26(24). 6453–6463. 117 indexed citations
16.
Serritella, Anthony V. & Christine M. Bestvina. (2020). Anaplastic Lymphoma Kinase Mutation–Positive Non–Small Cell Lung Cancer. Thoracic surgery clinics/Thorac. surg. clin.. 30(2). 137–146. 5 indexed citations
17.
Hirai, Taishi, Anthony V. Serritella, Stephanie A. Besser, et al.. (2019). Performance of the right ventricular outflow tract/aortic diameter as a novel predictor of risk in patients with acute pulmonary embolism. Journal of Thrombosis and Thrombolysis. 50(1). 165–173. 4 indexed citations
18.
Koga, Minori, Anthony V. Serritella, Akira Sawa, & Thomas W. Sedlak. (2015). Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophrenia Research. 176(1). 52–71. 128 indexed citations
19.
Xu, Risheng, Anthony V. Serritella, Tanusree Sen, et al.. (2013). Behavioral Effects of Cocaine Mediated by Nitric Oxide-GAPDH Transcriptional Signaling. Neuron. 78(4). 623–630. 24 indexed citations
20.
Koga, Minori, Anthony V. Serritella, Akiko Hayashi‐Takagi, et al.. (2011). Glutathione is a physiologic reservoir of neuronal glutamate. Biochemical and Biophysical Research Communications. 409(4). 596–602. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026